A patient at risk of suicide
114 results
1 - 100
A patient at risk of suicide 
Guidelines for decreasing the risk of suicide- Risk of suicide in adolescence
- Ketamine reduces suicidal ideation quickly, but may not reduce the short-term likelihood of suicide attempts
- USPSTF: Evidence insufficient to recommend routine screening for suicide risk
- Are some antidepressants safer than others regarding suicide risk?
- Lithium prevents suicide in patients with mood disorder
- Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents
- Completed suicide risk highest after attempted suicide by those with depression, schizophrenia
- Planning the treatment of patients with depression
- Factors associated with suicide after parasuicide in young people
- USPSTF 2023: Screening recommended for depression in adults, including in pregnant and postpartum persons (B recommendation)
Newer generation antidepressants for depressive disorders in children and adolescents- Neuropsychiatric disorders associated with glucocorticoids
- Pharmacological interventions for self‐harm in adults
- Psychosocial and pharmacological treatments for deliberate self harm: Cochrane systematic review
- Pharmacological interventions for self‐harm in adults
- Lithium for maintenance treatment of mood disorders
- Adolescent psychosis
- Borderline personality disorder
- Bipolar disorder
- Psychosocial interventions for preventing and treating depression in dialysis patients
- Recognition and diagnostics of depression
- Lithium versus antidepressants in the long‐term treatment of unipolar affective disorder
- Eating disorders among children and adolescents
- Antidepressants for anorexia nervosa
- Rimonabant: weight loss at risk of serious adverse events
- New generation antidepressants for depression in children and adolescents: a network meta‐analysis
- Postpartum psychosis and other postpartum mental disorders
- Psychosocial interventions for self‐harm in adults
- Treatment of depression in association with other psychiatric disorders
- USPSTF 2022: Screening for major depressive disorder recommended in adolescents aged 12 to 18 years (B recommendation)
- Benefits = harms for duloxetine as treatment for stress urinary incontinence
- Varenicline and bupropion and suicidal behaviour
- Acute psychosis
- Depression in the elderly
- Interventions for preventing injuries in problem drinkers
- Computer game effective to reduce depression symptoms in adolescents
- Anxiety disorder
- Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus
- Magnetic seizure therapy for treatment‐resistant depression
- Integrated exposure-based therapy effective for comorbid PTSD and substance dependence
- Amitriptyline for depression
- Adolescent substance abuse
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
- Interventions for self‐harm in children and adolescents
- Intensive therapy = standard weekly cognitive therapy for PTSD
- Continued prescription of antidepressant drugs for relapse prevention in depression
- Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD): Cochrane systematic review
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome
- Antidepressants versus placebo for generalised anxiety disorder (GAD)
- Haloperidol alone or in combination for acute mania
- Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
- Interventions for self‐harm in children and adolescents
- Injuries in problem drinkers
- Psychosocial interventions for self‐harm in adults
- Interferon alpha for chronic hepatitis D
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Psychopharmacotherapy in children and adolescents
- Mental disorders during pregnancy
- Bladder pain syndrome (interstitial cystitis)
- Family intervention for schizophrenia
- Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults
- Baclofen for alcohol use disorder
- Psychological therapies for people with borderline personality disorder
- Pharmacological treatment of depression
- Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults